Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 13, 2013 23:32 ET | Source: VIVUS, Inc.

VIVUS Extends Invitation to First Manhattan for Three of Their Nominees to Join the Board of Directors

VIVUS Offers a Compromise to End the Proxy Contest VIVUS Stockholders Encouraged to Vote the GOLD Card in Favor of VIVUS Nominees and to Notify FMC of Your Support for This Compromise MOUNTAIN...
July 11, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS Reminds Stockholders to Vote the GOLD Proxy Card by Telephone or Internet Today

MOUNTAIN VIEW, Calif., July 11, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company"), a pharmaceutical company commercializing and developing innovative, next-generation therapies to...
July 10, 2013 07:00 ET | Source: VIVUS, Inc.

Strong Support for VIVUS's Board and Management Team Among Influential Financial Analysts

VIVUS's Board and Management Team Are Executing on the Right Strategy to Maximize Stockholder Value VIVUS's Board Urges Stockholders to Vote FOR the Board's Nominees on the GOLD Proxy Card...
July 09, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS Board and Management Team Successfully Executing Plan to Unlock the Full Potential of Qsymia

MOUNTAIN VIEW, Calif., July 9, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company"), a pharmaceutical company commercializing and developing innovative, next-generation therapies to...
July 09, 2013 03:00 ET | Source: VIVUS, Inc.

VIVUS Announces Avanafil Partnership With Menarini

Menarini to Launch and Market SPEDRA in 40 Countries in Europe and Abroad VIVUS to Receive Upfront Payment Plus Milestones and Royalties Over the Term of the Agreement MOUNTAIN VIEW, Calif.,...
July 05, 2013 07:00 ET | Source: VIVUS, Inc.

Two Leading Proxy Advisory Firms Reject FMC's Attempt to Take Control of VIVUS's Board

ISS Supports Majority of VIVUS's Directors Retaining Control Glass Lewis Recommends Stockholders Do Not Vote for Any FMC Nominees Glass Lewis Notes VIVUS is "Making Encouraging Progress to...
July 02, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS to Present at Upcoming Investor Conference

MOUNTAIN VIEW, Calif., July 2, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that management will present an overview of the company at the following investment...
July 02, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS Mails Letter to Stockholders

MOUNTAIN VIEW, Calif., July 2, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company"), a pharmaceutical company commercializing and developing innovative, next-generation therapies to...
July 01, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS Announces Initial Availability of Qsymia(R) Through Certified Retail Pharmacies

MOUNTAIN VIEW, Calif., July 1, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced the initial availability of Qsymia® (phentermine and topiramate extended-release) capsules CIV in...
June 28, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS Clarifies Additional Misstatements by First Manhattan Co.

MOUNTAIN VIEW, Calif., June 28, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company"), a pharmaceutical company commercializing and developing innovative, next-generation therapies to...